Tau PET has also been used to differentiate AD dementia from other neurodegenerative diseases such as frontotemporal lobar degeneration (FTLD) disorders based on the location of tau protein in the brain (Abbasi, 2020). The gene discussed is MAPT; the disease is neurodegenerative disease.